肝硬化脾功能亢进并发消化道出血双介入治疗66例临床分析  

Hypersplenism with liver cirrhosis complicated by gastrointestinal bleeding double intervention clinical analysis of 66 cases

作　　者：翟红军[1] 

机构地区：[1]河南省濮阳市人民医院放射科,河南濮阳457000

出　　处：《中国当代医药》2011年第6期26-27,共2页China Modern Medicine

摘　　要：目的:探讨肝硬化脾功能亢进并发消化道出血双介入治疗的临床疗效。方法:分析总结66例经皮肝穿曲张静脉栓塞术(PTO)及部分脾栓塞术(PSE)进行双介入栓塞(DIE)治疗肝硬化门脉高压引起的食管、胃底曲张静脉出血及脾功能亢进。结果:行DIE治疗成功率为88%。静脉曲张不同程度缓解,脾功能亢进缓解,止血效果良好。肝功能及血细胞3个月左右稳定在正常范围。结论:行DIE治疗较临床手术损伤小、痛苦少、操作简单、并发症较轻微,是临床及放射科医生值得推广的非手术治疗方法。Objective： To investigate the concurrent liver cirrhosis and hypersplenism dual interventional therapy for gastrointestinal bleeding in clinical efficacy. Methods： Summary of 66 cases of percutaneous transhepatic variceal embolization （PTO） and partial splenic embolization （PSE） for dual embolization （DIE） treatment of portal hypertension caused by esophageal, gastric variceal bleeding and hypersplenism hyperthyroidism. Results： The line DIE treatment success was 88%. Varying degrees of ease varicose veins, some of hypersplenism disappeared, a good hemostatic effect. Liver function and blood cell was about 3 months and stable in the normal range. Conclusion： DIE treatment of clinical surgery than simple injury and less painful, less serious complications, is the clinical and radiologists should be promoted non-surgical treatment.

关 键 词：肝硬化脾功能亢进 消化道出血 双介入治疗 

分 类 号：R57[医药卫生—消化系统]